The product of the retinoblastoma susceptibility gene RBI (Rb) is likely to function as an inhibitor of cell growth. Previous studies have suggested that certain growthsuppressing effects of Rb are exerted in GO/GI phase and that phosphorylation can inactivate these functions. We tested this hypothesis by examining the expression and state of phosphorylation of Rb in several lineages of primary hematopoietic cells that spontaneously arrest in Go phase. Resting lymphocytes were found to express only unphosphorylated Rb, but phosphorylation of Rb occurred as the cells entered S phase in response to mitogens. In contrast, although monocytes and granulocytes also expressed high levels of unphosphorylated Rb, these terminally differentiated cells did not phosphorylate Rb, nor could they exit from G1 phase in response to growth factors. Thus, Rb phosphorylation appears linked to the ability of a cell to synthesize DNA. In T and B lymphocytes, Rb protein increased 8-fold after stimulation, while RB1 RNA levels increased 2-to 4-fold. Nuclear run-on assays and measurement of RB1 RNA half-life in T cells suggested that the increased RNA abundance was, at least in part, due to increased RNA stability. By contrast, Rb protein levels did not increase in either monocytes or granulocytes after stimulation, although RB1 RNA levels did increase in monocytes. Thus, there are lineage-specific differences in both the regulation of Rb phosphorylation and RBI gene expression in lymphoid and myeloid cells. 
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Mutational inactivation of the retinoblastoma susceptibility gene (RBI) predisposes to the development of hereditary and sporadic retinoblastoma (1) (2) (3) (4) (5) (6) (7) . Moreover, RB) defects have been observed in cell lines and fresh tumor tissue derived from patients with small cell lung carcinoma (8) , breast cancer (9) , osteogenic sarcomas (4) , and bladder carcinoma (10) , suggesting that the loss of RBI gene function can contribute to the loss of growth regulation in several different cell lineages. In retinoblastoma and osteosarcoma cell lines, the neoplastic phenotype can be suppressed by replacement of the RBI gene by retroviral-mediated gene transfer (11) . RBI is located on chromosome 13q14 (3) and encodes a series of differentially phosphorylated nuclear proteins (p110-114Rb) (12) . Further evidence that the product ofthe RBI gene (Rb) is involved in growth regulation comes from observations that transforming proteins ofthree different DNA tumor viruses form specific complexes with Rb, including simian virus 40 (SV40) large tumor (T) antigen (13) , adenovirus ElA (14) , and human papilloma virus E7 (15) . For T antigen, it appears that complex formation with Rb contributes to its transforming action, possibly by inactivating one or more aspects of Rb growth-suppressing activity.
The mechanism by which Rb regulates cell proliferation is not yet understood, but recent evidence suggests that phosphorylation of Rb may be linked to control of Rb function. T antigen binds preferentially to unphosphorylated Rb, pl1ORb, but not to phosphorylated Rb, pp112-114Rb (16) . Further, T antigen does not alter the relative abundance of these species, suggesting that pljoRb, and not pp12-1142Rb, can perform those elements of Rb growth-suppression function that T antigen can perturb (16) . In various primary cells and cell lines, p1jORb was detected only in Go/Gj phase, whereas in S and G2 phases, pp112-114Rb was the predominant species (17) (18) (19) (20, 21) , they cannot be induced to synthesize DNA or to undergo mitosis (22) and, thus, are terminally differentiated. We present data here consistent with a role for Rb in regulating G1 exit and also evidence of lineage-specific posttranscriptional regulation of the RB) gene. 
MATERIALS AND METHODS
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Monocytes were purified from erythrocyte rosette-depleted MNC by plastic adherence and contained >90% CD14' cells and <10% of either CD2' or CD20' cells. In some experiments, an erythrocyte rosette negative fraction was used without plastic adherence to avoid activation of monocytes (nonadhered monocytes) and typically contained 70-80%o CD14+ cells, which were further cultured in polypropylene tubes (Falcon) to avoid activation of cells by plastic (23) . Granulocytes were prepared by dextran sedimentation (24) . An interleukin 2-dependent human T-cell clone was obtained from Chikao Morimoto (Dana-Farber Cancer Institute). Thymocytes were obtained from thymectomy specimens (provided by Michael Caligiuri, Dana-Farber Cancer Institute). All samples were obtained after informed consent of donors and under institutional review board-approved protocols.
Cells were cultured at 2-5 x 106 cells per ml in RPMI 1640 medium (GIBCO) supplemented with 10% heat-inactivated fetal bovine serum (GIBCO) at 370C with 5% CO2. Endotoxin content of fetal bovine serum was <5 pg/ml by limulus amoebocyte assay. The following agents were used as stimulants: phytohemagglutinin P (PHA) (Wellcome) at 2 pug/ml; mitogenic anti-CD2 monoclonal antibodies anti-T112 and -T113 (Stuart Schlossman, Dana-Farber Cancer Institute) (25) at a 1:1000 dilution of ascites; Cowan strain Staphylococcus aureus (SAC, Calbiochem) at 1:10,000; lipopolysaccharide (LPS, Escherichia coliOlll:B4, Sigma) at 100 ng/ml; purified recombinant granulocyte-macrophage colonystimulating factor (GM-CSF) (Genetics Institute, Cambridge, MA) at 250 ng/ml; and recombinant granulocyte colonystimulating factor (G-CSF) (Genetics Institute) at a 1:1000 dilution of G-CSF cDNA-transfected Chinese hamster ovary cell line supernatant.
Cell Cycle Analysis. Cell cycle analysis was performed by staining DNA with propidium iodide and flow cytometric analysis (17) . Northern (RNA) Blot Analysis, RNA Half-Life Analysis, and Nuclear Run-on Assays. Northern blotting by using total cellular RNA was performed as described (26) . RBI gene expression was detected by using a 3.5-kilobase (kb) EcoRI fragment of RB1 cDNA (4) labeled with [32P]dCTP (27) . RNA half-life and nuclear run-on assays were performed as described (26, 28) . Human CD2 cDNA (29) in the CDM8 vector was obtained from Brain Seed (Massachusetts General Hospital, Boston); interleukin 1(3 cDNA in the pSP64 vector was obtained from Gordon Wong (Genetics Institute, Cambridge, MA). A mouse f-actin cDNA was used to reprobe blots, and the pUR290 expression vector (30) was used as a negative control.
Immunologic Blot Analysis. Cells were washed with Trisbuffered saline (25 mM Tris-HCl, pH 8.0/150 mM NaCl) and lysed for 30 min at 4°C with 0.25 ml of lysis buffer [50 mM Tris HCl, pH 8/120 mM NaCI/0.5% Nonidet P-40/100 mM NaF/200 AM sodium orthovanadate containing protease inhibitors (10 ,ug each of aprotinin, phenylmethylsulfonyl fluoride, and leupeptin; Sigma)]. Immunoblotting was performed as described (17) by using a 1:200 dilution of the anti-Rb monoclonal antibody, RB-PMG3-245 or -340 (Pharmingen, San Diego), for 12 hr and developed with alkaline phosphatase-conjugated rabbit anti-mouse IgG (Promega) (13) . Alkaline phosphatase treatment of anti-Rb immune complexes was performed as described (16) .
RESULTS
Phosphorylation of the RB) Gene Product in Normal Hematopoietic Cells. The expression and phosphorylation status of Rb were analyzed in fresh, primary hematopoietic cells by immunologic blotting using anti-Rb monoclonal antibody Rb-PMG3-245 (which reacts with both p11ORb and pp112-114Rb) (13) . Resting T cells were found to contain p11ORb, but not pp1l2-114Rb (Fig. LA) tively. In parallel with the entry of a fraction ofthese cells into S, the appearance of pl12-114Rb was observed (Fig. lA) .
Similar results were observed with anti-Rb antibody 340, which recognizes a distinct epitope (E. Huang, personal communication). The increase in Rb protein phosphorylation was also observed after stimulation with anti-CD2 monoclonal antibodies (17) . In addition to the de novo appearance of phosphorylated Rb, the total amount of Rb protein increased 8-fold in response to either PHA or CD2 stimulation (Fig. lA) . To confirm that the slower migration of ppll2-114Rb was solely due to phosphorylation (16), anti-Rb immunoprecipitates containing this species were treated with alkaline phosphatase, which eliminated the pp112-114Rb bands but did not alter the migration of p1lORb (data not shown).
Lower molecular mass immunoreactive bands (<110 kDa) of undetermined origin were seen in most, but not all, analyses of hematopoietic cells examined. Such bands have been reported in other normal cells (32) .
Like T cells, resting B lymphocytes also constitute a Go cell population and can be induced to reenter the cell cycle with mitogens. Only p11(Rb was observed in resting splenic B cells, whereas overtly phosphorylated Rb protein appeared after stimulation with SAC for 3 days (Fig. 1B) . The Fig. 1 C and D) . These three stimulants were selected because they are growth factors for myeloid progenitor cells (GM-CSF and G-CSF) or because they cause cell activation, including induction of the CD11b adhesion protein, enhancement of the respiratory burst in neutrophils (LPS, GM-CSF, G-CSF) (34) (35) (36) (37) (38) (39) , and induction of cytokine gene expression in the monocyte (LPS and GM-CSF) (40, 41 Fig. 2A ). An interleukin 2-dependent T-cell clone and fresh normal thymocytes also contained detectably more RB1 RNA than resting T cells (Fig. 2B) . In purified splenic B lymphocytes, RB1 RNA also increased by 1.5-to 2-fold (when compared with actin RNA by densitometry) in multiple experiments after 3 days of SAC stimulation (Fig. 2C) . Unexpectedly, in monocytes activated by exposure to fetal bovine serum (FBS), plastic adherence, LPS, or GM-CSF, the level of RB1 RNA also increased 5-to 8-fold (Fig. 3) , despite the lack of any increase in Rb protein abundance (cf. Fig. 1C ). In contrast, the steady-state level ofRB1 RNA in neutrophils was unaffected by treatment with GM-CSF or G-CSF for 2-24 hr in multiple experiments (Fig. 3) . The basis for RB1 RNA induction in T cells and monocytes was further investigated by estimating changes in transcription rate by nuclear run-on assays and measuring RNA stability in the presence of actinomycin D. No significant change in the rate of RBI transcription was noted after stimulation of either T cells or monocytes (Fig. 4A) . The half-life of RB1 RNA in freshly isolated monocytes was 2 hr, and this increased, modestly, to 3.5 hr after plastic adherence for 24 hr (Fig. 4B) . A more impressive increase in RB1 RNA half-life was noted in T cells, where it was found to be 2 hr before stimulation with PHA and 6 hr after PHA stimulation. Thus, the increase in RB1 RNA observed in response to stimulation of T cells and monocytes is posttranscriptional. These data, summarized in Go/G1 phase during differentiation and because certain lineages (lymphoid cells) can then enter S phase in response to specific mitogens, whereas others (myeloid cells) cannot (20) (21) (22) . All hematopoietic cells examined contained readily detectable levels of unphosphorylated Rb. Treatment of resting lymphocytes with mitogens induced Rb phosphorylation at the time of onset of DNA synthesis, whereas terminally differentiated granulocytes and monocytes were unable to generate phosphorylated Rb or to exit GO/G1 phase.
Thus, myeloid cells may lack, or be unable to activate, the specific Rb kinase that is expressed in lymphoid cells and, therefore, cannot overcome the G1 boundary block provided, in part, by the presence of unphosphorylated Rb. The available data do not exclude the possibility that Rb promotes entry into Go phase and that its phosphorylation promotes exit therefrom, with the latter effect facilitating entry into S phase. It is also possible that granulocytes and monocytes contain excessive phosphatase activity that neutralizes the effect of an active Rb kinase.
Conceivably, phosphorylation ofpllORb is a consequence, rather than an effector, of G1 exit. However, the observation that SV40 T antigen binds only to pllORb and not to its phosphorylated derivatives, and the strong genetic correlation between T antigen-Rb complex formation and T antigen transforming activity, suggests that the growth-suppressing function ofRb is most likely to be exerted in G1 phase (13, 16) . Thus, it seems more likely that Rb phosphorylation contributes to overcoming a G1 block rather than simply responding to it.
If, as proposed, Rb is a regulator of the G1/S transition in hematopoietic and other cells, it is not the only such regulator. Gewirtz et aL (43) have shown that the product of the c-myb gene is required by T lymphocytes for entry into S phase. Treatment of resting T cells with PHA leads to an increase in the abundance of c-myb RNA and protein. Pretreatment of T cells with a c-myb antisense oligomer blocked entry into S phase, but not cellular activation. Immature myeloid cells have been shown to express high levels ofc-myb RNA, which decreases precipitously upon induction of differentiation to monocytes (44) . Thus, it is likely that multiple events contribute to S phase entry in hematopoietic cells. Conceivably, the ability to phosphorylate Rb and the ability to express c-myb are related in some manner. We have also demonstrated that expression of the RB1 gene is specifically and differently regulated in the various types of hematopoietic cells. In T cells, B cells, and monocytes activation of resting cells induced a 2-to 8-fold increase in steady-state RB1 RNA (Table 1) . By contrast, there was no change in RB1 RNA levels in neutrophils. Nuclear run-on and RNA half-life studies in T cells and monocytes suggested that increased RNA stability, and not transcriptional activation, might contribute to a significant fraction of the increase in RB1 RNA abundance. Activation of both T cells and monocytes is known to induce mechanisms that stabilize certain transcripts, notably those of cytokines such as GM-CSF, G-CSF, and monocyte colony-stimulating factor; as well as protooncogenes such as c-myc and c-fos (26, 45, 46) . Posttranscriptional regulation of RB1 RNA stability has not previously been reported, but the presence of poly(AUUUA) destabilizing sequences, similar to those observed in cytokines and oncogenes, have been noted in both the human and murine RB1 cDNAs (47, 48) . RB1 RNA could be subject to a specific degradation system common to RNAs bearing this sequence (45) .
The increase in RB1 RNA was associated with an in- 
